Maze Therapeutics is translating novel genetic insights into lifesaving medicines, through an approach that integrates human genetics and functional genomics. The Company is focused on building a platform to discover and drug genetic modifiers, genes that can negate the harmful effects of other genes.
Type | Private | |
Founded | 2018 | |
HQ | Redwood City, CA, US | Map |
Website | mazetx.com |
Employees (est.) (Jan 2021) | 89 | (+8%) |
Cybersecurity rating | B | More |
Founding Date | 2018 |
Maze Therapeutics total Funding | $191 m |
Time since last funding | a year ago |
Maze Therapeutics investors | City Hill Ventures, ARCH Venture Partners, Third Rock Ventures, Foresite Capital, Casdin Capital, GV, Alexandria Venture Investments |
When was Maze Therapeutics founded?
Maze Therapeutics was founded in 2018.
Who are Maze Therapeutics key executives?
Maze Therapeutics's key executives are Charles Homcy, Tim Behrens and Brendan Bulik-Sullivan.
How many employees does Maze Therapeutics have?
Maze Therapeutics has 89 employees.
Who are Maze Therapeutics competitors?
Competitors of Maze Therapeutics include GenVec, Synchronicity Pharma and GeneQuine Biotherapeutics.
Where is Maze Therapeutics headquarters?
Maze Therapeutics headquarters is located at 123 Saginaw Dr, Redwood City.
Where are Maze Therapeutics offices?
Maze Therapeutics has offices in Redwood City and South San Francisco.
How many offices does Maze Therapeutics have?
Maze Therapeutics has 2 offices.
Receive alerts for 300+ data fields across thousands of companies